JOHN M. LEONARD - 19 Aug 2021 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: President and CEO, Director
Signature: /s/Glenn Goddard Attorney-In-Fact
Issuer symbol: NTLA
Transactions as of: 19 Aug 2021
Transactions value $: $-3,127,459
Form type: 4
Filing time: 20 Aug 2021, 18:14:06 UTC
Next filing: 25 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTLA	Common Stock	Options Exercise	$303,939	+22,682	+3.15%	$13.40	741,987	19 Aug 2021	Direct
transaction	NTLA	Common Stock	Sale	$-1,463,374	-9,726	-1.31%	$150.46	732,261	19 Aug 2021	Direct	F1, F2
transaction	NTLA	Common Stock	Sale	$-1,059,859	-6,993	-0.95%	$151.56	725,268	19 Aug 2021	Direct	F1, F3
transaction	NTLA	Common Stock	Sale	$-908,165	-5,963	-0.82%	$152.30	719,305	19 Aug 2021	Direct	F1, F4
holding	NTLA	Common Stock						58,415	19 Aug 2021	By Trust	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NTLA	Stock Option (right to buy)	Options Exercise	$0	-22,682	-8.28%	$0.000000	251,277	19 Aug 2021	Common Stock	22,682	$13.40	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.96, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.02 to $152.015, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.055 to $152.80, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
F5	Shares held by the John M. Leonard 2015 Irrevocable Trust.
F6	The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 134,583 shares as of August 19, 2021.